Anemia control in kidney transplant patients treated with methoxy polyethylene glycol-epoetin beta (Mircera): The anemiatrans group

Transplantation Proceedings

Volumn 42, Issue 8, 2010, Pages 2931-2934

  Sanchez Fructuoso A ^a   Guirado, L ^b   Ruiz, J C ^c   Torregrosa, V ^d   Gonzalez, E ^e   Suarez, M L ^f   Galleego R ^g  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; METHOXYPOLYETHYLENE GLYCOL EPOIETIN BETA; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINARY TRACT INFECTION;

ADULT; AGED; ANEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RETROSPECTIVE STUDIES;

EID: 77958545927     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.012     Document Type: Article

References (18)

1. M.R. Nampoory, K.V. Johny, and N. al-Hilali Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function Nephrol Dial Transplant 11 1996 177
2. Y. Vanrenterghem Anaemia after renal transplantation Nephrol Dial Transplant 19 suppl 5 2004 V54
3. Y. Vanrenterghem Anemia after kidney transplantation Transplantation 87 2009 1265
4. I.C. Macdougall Novel erythropoiesis-stimulating agents: a new era in anemia management Clin J Am Soc Nephrol 3 2008 200
5. MIRCERA® Summary of product characteristics 2007 F. Hoffmann-La Roche Ltd
6. E. Imbasciati, M. Bernardo, and P.L. Caraman Stable haemoglobin (Hb) levels are maintained with once-monthly C.E.R.A. in dialysis patients with varying C-reactive protein (CRP), albumin or dialysis adequacy Nephrol Dial Transplant 22 2007 vi412 (abstract SuO005)
7. F. Locatelli, G. Villa, and A.L. de Francisco Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administration Curr Med Res Opin 23 2007 969
8. J. Mann, F. Locatelli, and W. Sulowicz C.E.R.A. provides stable haemoglobin (Hb) levels in CKD patients on dialysis with and without coronary artery disease (CAD) or diabetes mellitus (DM) when administered once monthly Nephrol Dial Transplant 22 2007 vi409 (abstract SuO002)
9. W. Sulowicz, F. Locatelli, and J.P. Ryckelynck Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly Clin J Am Soc Nephrol 2 2007 637
10. V. Lezaic, L. Djukanovic, and V. Pavlovic-Kentera Recombinant human erythropoietin treatment of anemia in renal transplant patients Ren Fail 17 1995 705
11. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease Am J Kidney Dis 47 2006 S11
12. F. Locatelli, P. Aljama, and P. Barany Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure Nephrol Dial Transplant 19 suppl 2 2004 ii1
13. F. Locatelli, R.L. Pisoni, and T. Akizawa Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings Am J Kidney Dis 44 2004 27
14. R.L. Pisoni, J.L. Bragg-Gresham, and E.W. Young Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 44 2004 94
15. S. Fishbane, and J.S. Berns Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin Kidney Int 68 2005 1337
16. D.L. Regidor, J.D. Kopple, and C.P. Kovesdy Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients J Am Soc Nephrol 17 2006 1181
17. J.P. Ebben, D.T. Gilbertson, and R.N. Foley Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations Clin J Am Soc Nephrol 1 2006 1205
18. D. Gilbertson, J. Ebben, and A. Collins The effect of hemoglobin variability on hospitalization and mortality Nephrol Dial Transplant 21 suppl 4 2006 iv169